McKay RR, Kwak L, Crowdis J, Sperger JM, et al. Phase 2 multicenter study of enzalutamide in metastatic castration resistant prostate cancer to identify mechanisms driving resistance. Clin Cancer Res 2021 Apr 13. pii: 1078-0432.CCR-20-4616.
PMID: 33849963